🔗 Share this article

Chancellor Reeves has announced she is planning "specific action to deal with cost of living issues" in the upcoming financial statement.

In comments to the BBC, she stated that curbing inflation is a joint responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven developed nations this year and next.

Possible Utility Cost Interventions

Sources suggest the administration could take action to lower utility costs, for example by slashing the present 5% rate of VAT applied on energy supplies.

An additional possibility is to cut some of the government charges presently included in household expenses.

Budgetary Limitations and Analyst Expectations

The government will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for such actions.

The view from the majority of economists is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her declared debt limits.

Earlier on the same day, analysis indicated there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the lower end of expectations.

"There's a joint task between the central bank and the administration to bear down further on some of the drivers of price increases," the Chancellor told the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Pledges and Global Concerns

While much of the attention has been on likely tax rises, the Treasury chief said the most recent information from the OBR had not altered her vow to election pledges not to increase rates on income tax, sales tax or social security contributions.

She attributed an "unpredictable global environment" with growing geopolitical and trade concerns for the Budget revenue measures, probably to be targeted on those "with the broadest shoulders."

Global Trade Disputes

Commenting on concerns about the UK's trade ties with the Asian nation she said: "The UK's national security always are paramount."

Last week's statement by China to tighten export controls on critical minerals and other resources that are essential for advanced tech manufacturing led American leader the US President to threaten an additional 100% import tax on imports from the Asian country, raising the risk of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary described China's action "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "very concerned" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "damaging for the world economy and causes further headwinds."

"In my view there are areas where we need to challenge Chinese policies, but there are also important chances to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance correct."

The chancellor also affirmed she was collaborating with other major economies "regarding our own critical minerals strategy, so that we are less reliant."

Health Service Drug Pricing and Funding

Reeves also admitted that the cost the NHS spends on medicines could increase as a consequence of ongoing discussions with the Trump administration and its drugs companies, in return for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or canceling investments in the United Kingdom, with several attributing the insufficient payments they are receiving.

Recently, the government science advisor said the price the NHS pays for drugs would must increase to stop companies and pharmaceutical investment departing from the United Kingdom.

Reeves stated to media: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been available in the United Kingdom in the way that they are in other European countries."

"Our aim is to make sure that people receiving treatment from the National Health Service are able to obtain the top essential drugs in the globe. And so we are reviewing these issues, and... looking to attract more investment into the UK."